PRIVACY NOTICE
This application has been developed and/or commissioned by AstraZeneca AB ("we", “our” and “us”) of 151 85 Södertälje, Sweden with the assistance of trusted third-party vendors, who provide and support the technology. The application will collect certain personal data from you such as your login credentials (user ID and password). Other information that can be collected is technical information about your device, such as IP address, device type, device identifiers, browser type and version, and other standard server log information, system usage information such as time stamps and duration of use; location (to enable Bluetooth connections to study devices) and health related information such as blood pressure and medication (to enable you and your doctor to follow your progress). Our need to process your personal data is based on your explicit consent.
The main purpose of this application is to enable study participants perform some or all of these tasks remotely - collect health measurements remotely using connected devices, track their daily tasks, manage their medication schedule, initiate and complete a telemedicine visit, view their study visit schedule and study educational content, complete health related questionnaires and satisfaction surveys and provide regular reminders/notifications for study participants to complete specific tasks. The application is also designed to help AstraZeneca and Health Care Professionals (HCPs) in understanding the effectiveness and progress of the patient with the medication and ensure patient’s adherence to the various remote activities as defined in the protocol.
We may transfer your personal data to other AstraZeneca group companies and with third parties for technical support purposes, or in accordance with any legal obligations. Only your healthcare professional and staff working at the hospital will have access to data that personally identifies you. Any other parties will only have access to coded data so that you cannot be personally identified. Your personal information that is collected in this application may be shared with other AstraZeneca group companies (https://www.astrazeneca.com/global/en/AstraZeneca-Websites.html). Your data may also be shared with certain third parties such as: IT software providers involved in the development and maintenance of this Application; companies that provide services to AstraZeneca to conduct the clinical studies, organizations which collaborates with AstraZeneca on the clinical trials, health authorities and ethics committees who supervise the study, who approve the commercialization of the drug or who receive the adverse events reporting, auditors and consultants to verify our compliance with external and internal requirements; statutory bodies, law enforcement agencies and litigants, as per a legal reporting requirement or claim; and a successor or business partner to AstraZeneca or to an AstraZeneca group company in the event that it sells, divests or sets up a collaboration/joint venture for all or part of its business.
Such AstraZeneca entities and third parties may be based anywhere in the world, which could include countries that may not offer the same legal protections for personal data as your country of residence. AstraZeneca will follow local data protection requirements and its internal global privacy standard and will apply the necessary safeguards under the applicable law of the country transferring the data for such transfers. Irrespective of which country your Personal Data is transferred, We would only share your Personal Data under a strict ‘need to know’ basis and under appropriate contractual restrictions (such as AstraZeneca’s Binding Corporate Rules on https://www.astrazenecabindingcorporaterules.com/ and EU Standard Contract Clauses on https://ec.europa.eu/justice/data-protection/international-transfers/transfer/index_en.html. You may be entitled to receive a copy of AstraZeneca’s Binding Corporate Rules and/or the AstraZeneca’s EU Standard Contract Clauses upon request by contacting AstraZeneca on privacy@astrazeneca.com.
The study site and AstraZeneca are obliged by law to keep your coded data such as your medication intake, how you take your medication, response to questionnaires, for a period of up to 25 years after the end of the study or for as long as it is necessary in order to satisfy our legitimate business interests, legal obligations, or in order to establish, exercise or defend legal claims. After that your coded data will be deleted or anonymized. For more information on AstraZeneca internal Document Retention policy, you may go to www.astrazenecapersonaldataretention.com. Also, for additional information on the way your personal data would be handled and your privacy rights, please read the relevant section in your informed consent form.
You may contact your study doctor to request access to the data we hold about you, to correct any mistakes or to request deletion of the same in the first instance. You may contact AstraZeneca at www.astrazenecapersonaldataretention.com at any time to request access to the personal data we hold about you, to correct any mistakes or to request deletion of the same or withdraw your consent to certain types of processing of your personal data. You may also have a right to data portability to another Data Controller under certain circumstances. If such a request places AstraZeneca or its affiliates in breach of its obligations under applicable laws, regulations or codes of practice, then AstraZeneca may not be able to comply with your request, but you may still be able to request that we block the use of your personal information for further processing.
AstraZeneca has assigned a data protection officer responsible for overseeing AstraZeneca’s compliance with EU and UK data protection laws, which you may contact at privacy@astrazeneca.com or by mail at the Global Data Protection Officer, Astra Zeneca Middlewood Court, Silk Road, Macclesfield, Cheshire SK10 2NA, in case of any questions or concerns regarding the processing of your personal data. If AstraZeneca’s processing of your personal data is covered by EU or UK law, you can also lodge a complaint with the corresponding data protection supervisory authority in your country of residence. You can find the relevant EU supervisory authority name and contact details under https://edpb.europa.eu/about-edpb/board/members_en and the UK data protection supervisory authority’s contact details under https://ico.org.uk/global/contact-us/
Stopping to use the application will not affect your usual care or participation in this study unless the use of this mobile application is required by the Study protocol. Please also see the section called “Do I have to take part?” in the Informed Consent Form for further information. If you want to stop using the Application, please stop providing data to the Application and inform your Study Doctor about this. Please also see the section called “What will happen if I want to quit the study” in the Informed Consent Form for further information.
Last Updated 2 June 2022